V. Ogourtsov
Papers
1
Total Citations
10
H-Index
1
About
V. Ogourtsov is a leading figure in the automation of cell therapy manufacturing, with a primary focus on the scalable production of mesenchymal stromal cells (MSCs). Their most impactful work centers on the development of the AUTOSTEM platform, a closed, scalable, and automated robotic system designed for the manufacture of bone marrow-derived MSCs. This seminal 2017 paper, which has garnered over 10 citations, represents a critical step toward translating cell therapies from the lab bench to clinical application by addressing the key challenges of reproducibility, sterility, and cost-effectiveness. Ogourtsov’s contributions are foundational to the field of bioprocessing, offering a practical solution for producing therapeutic cells under Good Manufacturing Practice (GMP) conditions. Their work is particularly notable for integrating robotics and closed-system design, enabling high-throughput, consistent cell production while minimizing contamination risks. For students and researchers interested in regenerative medicine or biomanufacturing, Ogourtsov’s research provides a blueprint for the future of automated cell therapy, bridging the gap between experimental protocols and clinical-grade manufacturing.
Research Focus
Key Achievements
Top Papers
- 1